ZYL-314

N/A

Report date: 2023/04/02 21:28:26
NME

Base Information

Drug NameZYL-314
Drug Alias NameZYL314
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor agonistsSerotonin 2a (5-HT2a) receptor agonists
TargetsSerotonin 1a (5-HT1a) receptorSerotonin 2a (5-HT2a) receptor
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesZylorion
China Registration ClassN/A

Develop Information

Active CompaniesZylorion
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A